-
1
-
-
0030947754
-
Atorvastatin: A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias
-
May
-
(1997)
Drugs
, vol.53
, pp. 828-847
-
-
Lea, A.P.1
McTavish, D.2
-
2
-
-
0033588470
-
Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
-
(1999)
Life Sci
, vol.65
, Issue.13
, pp. 1329-1337
-
-
Moghadasian, M.H.1
-
4
-
-
0028200059
-
Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase
-
(1994)
Am J Cardiol
, vol.73
, Issue.SUPPL. D
-
-
Blum, C.B.B.1
-
5
-
-
0029818771
-
Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease
-
Sep
-
(1996)
Clin Cardiol
, vol.19
, pp. 683-689
-
-
Rackley, C.E.1
-
6
-
-
0026567257
-
Hepatic and non-hepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors
-
Jan 24
-
(1992)
Biochim Biophys Acta
, vol.1123
, pp. 133-144
-
-
Bocan, T.M.A.1
Ferguson, E.2
McNally, W.3
-
12
-
-
0029113047
-
Lipid-lowering activity of atorvastatin and lovastatin in rodent species: Triglyceride-lowering in rat correlates with efficacy in LDL animal models
-
Oct
-
(1995)
Atherosclerosis
, vol.117
, pp. 237-244
-
-
Krause, B.R.1
Newton, R.S.2
-
17
-
-
0033973214
-
Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: Effect of triglyceride reductions with atorvastatin
-
(2000)
Metabolism
, vol.49
, Issue.2
, pp. 167-177
-
-
Le, N.-A.1
Innis-Whitehouse, W.2
Li, X.3
-
31
-
-
0032478236
-
Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia
-
Mar
-
(1998)
Atherosclerosis
, vol.137
, pp. 197-203
-
-
Simons, L.A.1
Sullivan, D.2
Simons, J.3
-
35
-
-
0035830412
-
Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance
-
Jan 2
-
(2001)
Circulation
, vol.103
, pp. 113-118
-
-
Feron, O.1
Dessy, C.2
Desager, J.-P.3
-
39
-
-
0003339920
-
Effect of the new HMG-CoA reductase inhibitor atorvastatin on human vascular cell growth in mono- and cocultures in comparison to lovastatin
-
Aug
-
(1997)
Eur Heart J
, vol.18
, Issue.ABSTR. SUPPL.
, pp. 37
-
-
Axel, D.I.1
Riessen, R.2
Runge, H.3
-
41
-
-
0002970719
-
Lipid-lowering and anti-aggregatory efficacy of atorvastatin in coronary heart disease patients with combined hyperlipidemia
-
May 24
-
(1999)
Atherosclerosis
, vol.144
, Issue.SUPPL. 1
, pp. 24
-
-
Viigimaa, M.1
Valkman, R.2
-
55
-
-
0032032592
-
Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)
-
[published erratum appears in Am J Cardiol 1998 Jul 1;82(1): 128] Mar 1
-
(1998)
Am J Cardiol
, vol.81
, pp. 582-587
-
-
Jones, P.1
Kafonek, S.2
Laurora, I.3
-
60
-
-
0031195278
-
A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia
-
Jul 1
-
(1997)
Am J Cardiol
, vol.80
, Issue.1
, pp. 39-44
-
-
Dart, A.1
Jerums, G.2
Nicholson, G.3
-
61
-
-
0035941786
-
Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): A prospective, randomised, double-blind trial
-
Feb 24
-
(2001)
Lancet
, vol.357
, pp. 577-581
-
-
Smilde, T.J.1
Van Wissen, S.2
Wollersheim, H.3
-
74
-
-
0032513756
-
Association of fibrinogen, C-reactive protein, albumin or leukocyte count with coronary artery disease: Meta-analyses of prospective studies
-
(1998)
JAMA
, vol.279
, pp. 1477-1482
-
-
Danesh, J.1
Collins, R.2
Appleby, P.3
-
77
-
-
0032499382
-
Statins and fibrinogen
-
May 9; discussion 1431-2
-
(1998)
Lancet
, vol.351
, pp. 1430
-
-
Black, D.M.1
-
105
-
-
0035897696
-
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel III)
-
May 16
-
(2001)
JAMA
, vol.285
, Issue.19
, pp. 2486-2497
-
-
-
106
-
-
0028072711
-
Prevention of coronary heart disease in clinical practice: Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension
-
Oct
-
(1994)
Eur Heart J
, vol.15
, pp. 1300-1331
-
-
Pyörälä, K.1
De Backer, G.2
Graham, I.3
-
118
-
-
0000474621
-
ZD4522 is superior to atorvastatin in decreasing low density lipoprotein cholesterol and increasing high density lipoprotein cholesterol in patients with type IIa or IIb hypercholesterolemia
-
Feb
-
(2001)
J Am Coll Cardiol
, vol.37
, Issue.2 SUPPL. A
-
-
Davidson, M.H.1
Ma, P.T.S.2
Stein, E.3
-
120
-
-
0033995230
-
Achievement of target plasma cholesterol levels in hypercholesterolaemic patients being treated in general practice
-
(2000)
Atherosclerosis
, vol.149
, Issue.1
, pp. 199-205
-
-
Barter, P.J.1
O'Brien, R.C.2
-
126
-
-
0031787156
-
Randomised, double-blind, parallel-group trial of atorvastatin and fluvastatin on plasma lipid levels in patients with untreated hyperlipidaemia
-
(1998)
Br J Cardiol
, vol.5
, Issue.11
, pp. 597-602
-
-
Schuster, H.1
Berger, J.2
Luft, F.C.3
-
129
-
-
0031781494
-
Evidence based approach for management of mixed hyperlipidemia
-
(1998)
Atherosclerosis
, vol.137
-
-
Gaw, A.1
-
133
-
-
0032004986
-
A randomized trial of the effects of atorvastatin and niacin in patients with combined hyperlipidemia or isolated hypertriglyceridemia
-
Collaborative Atorvastatin Study Group. Feb
-
(1998)
Am J Med
, vol.104
, pp. 137-143
-
-
McKenney, J.M.1
McCormick, L.S.2
Weiss, S.3
-
140
-
-
0032724923
-
Strategies for the management of diabetic dyslipidaemia
-
(1999)
Drugs
, vol.58
, Issue.SUPPL. 1
, pp. 47-51
-
-
Taskinen, M.-R.1
-
143
-
-
0002969193
-
Does the presence of either concurrent hypertension or non-insulin-dependent diabetes mellitus affect the efficacy and safety of atorvastatin in patients with hyperlipidaemia?
-
Apr
-
(1998)
Am J Hypertens
, vol.11
, Issue.PART. 2
, pp. 75
-
-
Black, D.M.1
Bakker-Arkema, R.2
Heinonen, T.3
-
144
-
-
4243816042
-
The Can-ADA Study: Do lipid parameters respond differently to atorvastatin therapy in ischemic heart disease subjects with and without type 2 diabetes?
-
Sep
-
(2000)
Can J Cardiol
, vol.16
, Issue.SUPPL. F
-
-
Bogaty, P.1
Leiter, L.2
Murray, P.3
-
147
-
-
23544460682
-
The ASSET Investigators. The efficacy and safety of atorvastatin versus simvastatin in mixed dyslipidemic patients with type 2 diabetes mellitus during 54 weeks
-
Jun
-
(2001)
Diabetes
, vol.50
, Issue.SUPPL. 2
-
-
Insull W., Jr.1
-
148
-
-
0035431019
-
The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia. The DALI Study: A double-blind, randomised placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia
-
Aug
-
(2001)
Diabetes Care
, vol.24
, Issue.8
, pp. 1335-1341
-
-
-
150
-
-
0032772992
-
Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia
-
Sep
-
(1999)
Atherosclerosis
, vol.146
, pp. 167-174
-
-
Hoogerbrugge, N.1
Jansen, H.2
-
154
-
-
0031904071
-
Effects of atorvastatin on serum lipids of patients with familial hypercholesterolaemia
-
Aug
-
(1998)
J Intern Med
, vol.244
, pp. 143-147
-
-
Hoogerbrugge, N.1
-
157
-
-
0031876986
-
Comparison of atorvastatin alone versus simvastatin ± cholestyramine in the management of severe primary hypercholesterolaemia (the Six Cities Study)
-
Jun
-
(1998)
Aust N Z J Med
, vol.28
, pp. 327-333
-
-
Simons, L.A.1
-
158
-
-
0031692691
-
Treating patients with documented atherosclerosis to National Cholesterol Education Program - Recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin
-
Sep
-
(1998)
J Am Coll Cardiol
, vol.32
, pp. 665-672
-
-
Brown, A.S.1
Bakker-Arkema, R.G.2
Yellen, L.3
-
159
-
-
0345034610
-
Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE trial)
-
Jul 1
-
(1999)
Am J Cardiol
, vol.84
, pp. 7-13
-
-
März, W.1
Wollschläger, H.2
Klein, G.3
-
160
-
-
0032748231
-
An assessment of the efficacy of atorvastatin in treating patients with dyslipidaemia to target LDL-cholesterol goals: The Atorvastatin Matrix Study
-
(1999)
Int J Clin Pract
, vol.53
, Issue.7
, pp. 509-513
-
-
McVey, D.1
Patel, H.2
Eminton, Z.3
-
162
-
-
0035371373
-
Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidaemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH)
-
(2001)
Am Heart J
, vol.141
, pp. 949-956
-
-
McPherson, R.1
Angus, C.2
Murray, P.3
-
163
-
-
0035943069
-
Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease
-
(2001)
Circulation
, vol.104
, pp. 387-392
-
-
Schartl, M.1
Bocksch, W.2
Koschyk, D.3
-
164
-
-
0035804846
-
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: A randomized controlled trial
-
Apr 4
-
(2001)
JAMA
, vol.285
, Issue.13
, pp. 1711-1718
-
-
Schwartz, G.G.1
Olsson, A.G.2
Ezekowitz, M.D.3
-
165
-
-
0033536298
-
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators
-
Jul 8
-
(1999)
N Engl J Med
, vol.341
, pp. 70-76
-
-
Pitt, B.1
Waters, D.2
Brown, W.V.3
-
166
-
-
0002891617
-
Can aggressive lipid-lowering therapy provide additional clinical benefit? Subgroup analysis of the Atorvastatin VErsus Revascularization Treatments (AVERT) trial
-
Aug-Sep
-
(2000)
Eur Heart J
, vol.21
, Issue.SUPPL.
, pp. 157
-
-
Brown, W.V.1
Avert, I.2
-
201
-
-
0002895329
-
The cost-effectiveness of statins: Evidence from the ACCESS trial
-
Mar-Apr
-
(2001)
Value Health
, vol.4
, Issue.2
, pp. 109
-
-
Smith, D.G.1
-
202
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study Group (4S)
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
203
-
-
0035077896
-
Cost-minimization analysis of simvastatin versus atorvastatin for maintenance therapy in patients with coronary or peripheral vascular disease
-
(2001)
Clin Ther
, vol.23
, Issue.2
, pp. 276-283
-
-
Attanasio, E.1
Russo, P.2
Allen, S.E.3
-
206
-
-
0027731644
-
Adverse reactions profile: 10. simvastatin and pravastatin
-
(1990)
Prescr J
, vol.33
, pp. 217-220
-
-
Thompson, G.R.1
-
209
-
-
0034052167
-
Lipid lowering in the patient at risk - The next decade of discovery
-
(2000)
Br J Cardiol
, vol.7
, Issue.4
, pp. 223-230
-
-
Holme, I.1
-
210
-
-
0023025526
-
Is the relationship between serum cholesterol and the risk of premature death from coronary heart disease continuous or graded? Findings in 356,222 screenees of the Multiple Risk Factor Intervention Trial (MRFIT)
-
(1986)
JAMA
, vol.256
, pp. 2823-2828
-
-
Stamler, M.1
Wentworth, D.2
Neaton, J.D.3
-
213
-
-
0032487931
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
-
(1998)
N Engl J Med
, vol.339
, pp. 1349-1357
-
-
-
215
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TEXCAPS
-
(1998)
JAMA
, vol.279
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
-
216
-
-
0035825934
-
Pro and con: Low-density lipoprotein cholesterol lowering is and will be the key to the future of lipid management
-
Mar
-
(2001)
Am J Cardiol
, vol.8
, Issue.87 SUPPL. 5A
-
-
Pedersen, T.R.1
-
217
-
-
0034918812
-
Risk factors for a major coronary event after myocardial infarction in the Scandianavian Simvastatin Survival Study (4S): Impact of predicted risk on the benefit of cholesterol-lowering treatment
-
Jul
-
(2001)
Eur Heart J
, vol.22
, Issue.13
, pp. 1119-1127
-
-
Wilhelmsen, L.1
Pyorala, K.2
Wedel, H.3
-
218
-
-
0034085446
-
Aggressive lipid-lowering initiation abates new cardiac events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease
-
(2000)
Am J Cardiol
, vol.86
, Issue.2
, pp. 250-252
-
-
Isaacsohn, J.L.1
Davidson, M.H.2
Hunninghake, D.3
-
220
-
-
0000869291
-
A 4-year, placebo-controlled study of atorvastatin as prevention of CHD endpoints in patients with non-insulin dependent diabetes mellitus
-
May
-
(1997)
Diabetes
, vol.46
, Issue.SUPPL. 1
, pp. 363
-
-
Gmerek, A.1
McLain, R.2
Nawrocki, J.3
-
226
-
-
0035029222
-
Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolaemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial
-
(2001)
Am Heart J
, vol.141
, pp. 722-726
-
-
Raggi, P.1
Callister, T.Q.2
Davidson, M.3
-
227
-
-
0002967207
-
Assessing the effects of statins on atherosclerosis progression using intravascular ultrasound: Rationale and design of the REVERSAL study
-
(2001)
Atherosclerosis
, vol.2
, Issue.2 SUPPL.
, pp. 51-52
-
-
Nissen, S.1
-
230
-
-
0034533427
-
CAVEAT: A randomised, double-blind, parallel group evaluation of cerivastatin 0.4mg and 0.8mg compared to atorvastatin 10mg and 20mg once daily in patients with combined (type IIB) dyslipidaemia
-
(2000)
Br J Cardiol
, vol.7
, Issue.12
, pp. 780-786
-
-
Ma, P.1
Hegele, R.2
Yale, J.F.3
-
234
-
-
0034003329
-
Should reductase inhibitor therapy to lower cholesterol be instituted in the setting of an acute coronary event? [1]
-
(2000)
Atherosclerosis
, vol.149
, Issue.1
, pp. 215-216
-
-
Goldstein, M.R.1
-
236
-
-
0034119417
-
Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the Atorvastatin Versus Revascularization (AVERT) Trial
-
(2000)
Eur Heart J
, vol.21
, Issue.13
, pp. 1029-1031
-
-
Waters, D.1
-
237
-
-
0032554676
-
Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
-
(1998)
Circulation
, vol.97
, pp. 1440-1445
-
-
-
238
-
-
0032554688
-
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events Trial
-
(1998)
Circulation
, vol.97
, pp. 1446-1452
-
-
Sacks, F.M.1
Maye, L.A.2
Davis, B.R.3
|